Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Exosomes as therapeutic solutions for pancreatic cancer
Batoul Farran, Ganji Purnachandra Nagaraju
Drug Discovery Today (2020) Vol. 25, Iss. 12, pp. 2245-2256
Closed Access | Times Cited: 11

Showing 11 citing articles:

Emerging technologies and commercial products in exosome-based cancer diagnosis and prognosis
Mehdi Mohammadi, Hossein Zargartalebi, Razieh Salahandish, et al.
Biosensors and Bioelectronics (2021) Vol. 183, pp. 113176-113176
Closed Access | Times Cited: 76
Molecular insights to therapeutic in cancer: role of exosomes in tumor microenvironment, metastatic progression and drug resistance
Shikshya S. Panda, Rajeev Kumar Sahoo, Sambit K. Patra, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 8, pp. 104061-104061
Closed Access | Times Cited: 6
M2 Macrophages-Derived Exosomal miRNA-23a-3p Promotes the Progression of Oral Squamous Cell Carcinoma by Targeting PTEN
Jun Li, Yongjie Bao, Sisi Peng, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 6, pp. 4936-4947
Open Access | Times Cited: 10
Tumor-derived interleukin 35 mediates the dissemination of gemcitabine resistance in pancreatic adenocarcinoma
Huizhi Sun, Yi Ge, Jing Liu, et al.
Oncogene (2024) Vol. 43, Iss. 11, pp. 776-788
Closed Access | Times Cited: 3
Formulation development, characterization and anti-cancer study of a nanocarrier based on albumin nanoparticles and exosome for carboplatin sustained release
Maryam Saeidifar, Ali Akbar Saboury, Robert B. Macgregor
Journal of Molecular Liquids (2024) Vol. 398, pp. 124230-124230
Closed Access | Times Cited: 3
Applications of plant‐derived extracellular vesicles in medicine
Yawen Zhu, Junqi Zhao, Haoran Ding, et al.
MedComm (2024) Vol. 5, Iss. 10
Open Access | Times Cited: 2
Targeting the tumor microenvironment of pancreatic ductal adenocarcinoma using nano-phytomedicines
B. P. Girish, Begum Dariya, Mastan Mannarapu, et al.
Seminars in Cancer Biology (2021) Vol. 86, pp. 1155-1162
Closed Access | Times Cited: 14
Proteomes of Extracellular Vesicles From Pancreatic Cancer Cells and Cancer-Associated Fibroblasts
Sharon Pan, Lisa A. Lai, Diane M. Simeone, et al.
Pancreas (2022) Vol. 51, Iss. 7, pp. 790-799
Open Access | Times Cited: 7
Recent nanotechnology advancements to treat multidrug-resistance pancreatic cancer: Pre-clinical and clinical overview
Abdullah K. Alshememry, Nasser B. Alsaleh, Nora Alkhudair, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 6
Survivin Splice Variant 2β Enhances Pancreatic Ductal Adenocarcinoma Resistance to Gemcitabine
Ryan N. Fuller, Janviere Kabagwira, Paul Vallejos, et al.
OncoTargets and Therapy (2022) Vol. Volume 15, pp. 1147-1160
Open Access | Times Cited: 5
LINC01094: A Key Long Non-Coding RNA in the Regulation of Cancer Progression and Therapeutic Targets
Qiang Yi, Gangfeng Zhu, Weijian Zhu, et al.
Heliyon (2024) Vol. 10, Iss. 18, pp. e37527-e37527
Open Access
Page 1

Scroll to top